Suchergebnisse - "antibodies"

PubPharm (8.505)

91

Anti-inflammatory drugs : from old classical ones to biotherapies and JAK inhibitors

enthalten in: Revue medicale de Liege | 2022

von Scheen, A.

92

Cases of eosinophilia in patients treated with Tocilizumab for rheumatoid arthritis

enthalten in: Revue medicale suisse | 2022

von Vallat, J. | Pieren-Salazar, A. | Zenklusen, C. | +1

93

Nouveaux traitements du myélome multiple

enthalten in: La Revue du praticien | 2022

von Schavgoulidze, A. | Perrot, A.

94

Aspects virologiques, diagnostic et variants du SARS-CoV-2

enthalten in: La Revue du praticien | 2022

von Helary, M. | Salmona, M. | Walle, �. | +7

95

Prise en charge médicale du Covid-19, hors réanimation

enthalten in: La Revue du praticien | 2022

von Javaux, C. | Ader, F.

96

Atypical New Lav Blot I (HIV-1 Western blot) profile with loss of antibodies to gp120, gp41 and polymerase in a HIV-1 subtype A infected patient at AIDS stage

enthalten in: Virologie (Montrouge, France) | 2022

von Guiraud, V. | Talb, Y. | Ramahefasolo, C. | +2

97

Characteristics of cardiac involvement in eosinophilic granulomatosis with polyangiitis

enthalten in: Annales de cardiologie et d'angeiologie | 2022

von Belhassen, A. | Toujani, S. | El Ouni, A. | +5

98

Blinatumomab as monotherapy in consolidation treatment after first relapse of Ph-CD19+ ALL in children over one year old

enthalten in: Bulletin du cancer | 2022

von Coppin, R. | Leruste, A.

99

Pembrolizumab plus chemotherapy combination - first line in PD-L1 positive (CPS≥10) metastatic and advanced triple-negative breast cancer

enthalten in: Bulletin du cancer | 2022

von Loison, R. | Loirat, D.

100

New drug approval : Sacituzumab govitecan in third line in advanced or metastatic triple-negative breast cancer

enthalten in: Bulletin du cancer | 2022

von Kabirian, R. | Da Silva, A.